Back to today’s briefing

Story perspectives

Metabolic Dysregulation: Key to Alzheimer's and Parkinson's Treatments?

4/1/2025

43 8

Summary

Story summary

Metabolic dysregulation is emerging as a crucial factor in neurodegenerative diseases such as Alzheimer's and Parkinson's. Recent research reveals the impact of glucose metabolism and mitochondrial dysfunction, sparking hope for antidiabetic drugs like metformin as potential treatments. This growing body of evidence calls for deeper exploration to pave the way for targeted therapies.

1 of 1

Story summary

Metabolic dysregulation is emerging as a crucial factor in neurodegenerative diseases such as Alzheimer's and Parkinson's. Recent research reveals the impact of glucose metabolism and mitochondrial dysfunction, sparking hope for antidiabetic drugs like metformin as potential treatments. This growing body of evidence calls for deeper exploration to pave the way for targeted therapies.